Analyst Ratings for Annexon Biosciences (ANNX)
ANNX Rating Summary
ANNX Price Target Summary
- Highest: $27.00 (Wells Fargo)
- Lowest: $7.00 (Goldman Sachs)
- Average: $16.38
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$16.38 (+380.2%)
* Over Last 12-Mos
Rating Score: 8.5 / 10
Percentile Rank: 86%
Avg. $ Target:
$16.38 (+380.2%)
* Over Last 12-Mos
Rating Score: 8.5 / 10
Percentile Rank: 86%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/13/2026 | Citizens | Jonathan Wolleben | Upgrade | Market Perform (Market Underperform) |
N/A (N/A) |
5.34 (3.41) |
-36.14% | Details |
| 5/12/2026 | Goldman Sachs » Updated 8/6/2026 |
Salveen Richter | New Coverage | Neutral (N/A) |
7.00 (N/A) |
5.68 (3.41) |
-39.96% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
